Irene Robinson

Pharma

Following landmark approval, Pfizer and BioNTech can use UK as test bed for cold chain distribution

Following the news that Pfizer/BioNTech’s COVID-19 vaccine BNT162b2 received emergency use approval from UK health authorities; Philipp Rosenbaum, PhD, Senior Infectious Diseases Analyst at GlobalData, a leading data and analytics company, offers his view: “The UK represents an ideal test bed for the delivery of Pfizer’s vaccine. The country’s small size, dense population and strong […]

Pharma

Lifetime diagnosed prevalent cases of asthma in 7MM set to surpass 89 million in 2029

The burden of diagnosed asthma is expected to increase at a compound annual growth rate (CAGR) of 0.31% from around 86.7 million cases in 2019 to 89.4 million cases in 2029 in the seven major markets (7MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Asthma: Epidemiology Forecast to 2029’, reveals […]

Medical Devices

ENT market set to fully recover from COVID-19 pandemic in 2021 and exceed market value of $10.6bn by 2025

The ear, nose and throat (ENT) medical device market has been significantly impacted by the COVID-19 pandemic, as mass closures of ENT clinics and postponement of elective ENT procedures in hospitals drove down device sales by approximately 76% in the worst-hit months of 2020. The ENT market will continue undergoing its surge in revenue in […]

Pharma

China to see over 14,400 diagnosed incident cases of acute lymphocytic leukemia by 2029 – the highest in the 8MM

The number of diagnosed incident cases of acute lymphocytic leukemia (ALL) in the eight major markets (8MM*) is projected to increase from 23,729 in 2019 to 26,482 in 2029, with an annual growth rate (AGR) of 1.16%, according to GlobalData, a leading data and analytics company. Urban China will have the highest number of cases […]

Pharma

Influenza cases down from last year in the US but COVID-19 increases the risks

In the Northern Hemisphere, flu season is beginning in conjunction with the COVID-19 pandemic, however, influenza-like activity remains low in the US, with 40% fewer cases of influenza-like illness (ILI) than in the same time last year. Nonetheless, with healthcare resources stretched thin as a result of the pandemic, the risk of a bad flu season […]

Pharma

Bladder cancer therapeutics market projected to exceed $5.5bn by 2028

The bladder cancer therapeutics market was valued at $670m in 2018 across the seven major markets (7MM*) and is expected to grow exponentially at a compound annual growth rate (CAGR) of 23.6% – accruing slightly less than $5.6bn in 2028, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Bladder Cancer Opportunity […]

Pharma

Acute lymphocytic leukemia market is forecast to reach $2.26bn by 2029

The acute lymphocytic leukemia (ALL) market has enjoyed explosive growth since 2015 and is expected to increase further, albeit at a slower pace, from $1.46bn in 2019 to $2.26bn in 2029 across the eight major markets (8MM*) at a moderate compound annual growth rate (CAGR) of 4.4%, according to GlobalData, a leading data and analytics […]

Pharma

US cannot wait on vaccines to curb pandemic as COVID-19 cases trend towards 100 million by July 2021

If the current trend in US COVID-19 cases continue, over 30% of the US population will have contracted the virus by July 2021, according to GlobalData forecasts Given that vaccines will need many more months to be approved, manufactured, and distributed to the general population, the US cannot rely only on vaccines to curb the […]

Oil & Gas

European oil companies lead way in renewable strategy with top six having over 28GW capacity in pipeline

European international oil companies (IOCs) are leading the way in terms of progressing strategies for renewable power growth, ahead of US players that have not, so far, made the same switch. The top six European firms have over 28GW of renewables capacity in the pipeline, with BP, Total and Equinor making up over 70% of […]

Pharma

Phase III data for Omecamtiv Mecarbil and Finerenone demonstrates reduced risk of cardiovascular events at AHA conference

A record number of late-breaking trials were submitted to the Annual Scientific Sessions of the American Heart Association (AHA) this year and unsurprisingly, a key theme of this year’s conference was the COVID-19 pandemic, says GlobalData, a leading data and analytics company. Fiona Chisholm, Managing Analyst at GlobalData, comments: “One notable study, which analyzed records […]

Pharma

Pancreatic ductal adenocarcinoma diagnosed incident cases set to reach 225,000 in 2029

The burden of diagnosed pancreatic ductal adenocarcinoma (PDAC) is expected to increase at an annual growth rate (AGR) of 2.60% from around 180,000 cases in 2019 to 225,000 cases in 2029 in the eight major markets (8MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Pancreatic Cancer – Epidemiology Forecast to […]

Pharma

Half of top 20 global innovative pharma companies by MCap reported positive MCap growth in Q3 2020

Half of the companies in a ranking of top 20 global innovative pharmaceutical firms by data and analytics company GlobalData reported positive market capitalization (MCap) growth in Q3*, with Pfizer and Daiichi Sankyo Co reporting double-digit percentage growth. The top 20 reported a mixed bag of increases and decreases in their MCap, and the overall […]

Pharma

Gmax BioPharm looking to enter competitive PAH market with early stage drug GMA301

Gmax Biopharm announced that the first patient has received its humanized monoclonal antibody drug, GMA301, as part of investigations around the drug’s efficacy for the treatment of pulmonary arterial hypertension (PAH). As the drug is administered intravenously, and can be dosed on a monthly schedule because of its long-lasting half-life, it may be more convenient […]

Oil & Gas

Global oil and gas contract activity report marginal increase during Q3 2020

The global oil and gas industry has witnessed a marginal increase in the number of oil and gas contracts from 1,104 in Q2 2020 to 1,136 in Q3 2020. This is in spite of challenges such as crude oil process and the COVID-19 outbreak, says GlobalData, a leading data and analytics company. The industry recorded […]

Pharma

FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1 diabetes space

If Provention Bio’s rolling Biologic License Application (BLA) submission to the FDA for teplizumab is approved, teplizumab will be the first disease-modifying therapy for type 1 diabetes (T1D). Teplizumab is one of the first therapeutics to demonstrate a disease-modifying effect for T1D. As it is a prevention therapy, it is expected to encourage early screening […]

Medical Devices

3D printing market set to surge to over $60bn by 2030, driven by medical 3D printing

Medical 3D printing is a fast growing market and growth is expected to continue in the future as the technology is replacing traditional prototype development approaches across various industries. The overall 3D printing market was valued at over $13bn by the end of 2019, and is expected to increase to $32bn by 2025, and over […]

Business Fundamentals

North America dominated global VC funding landscape during Q3 2020, while APAC emerged as bright spot

Global venture capital (VC) funding activity fluctuated during the third quarter (Q3) of 2020 due to inconsistent growth among different regions. However, North America continued to maintain its dominance, according to GlobalData, a leading data and analytics company. The number of VC funding deals that were announced globally declined from 1,787 in July to 1,531 in August before rising to […]

Pharma

Diagnosed prevalent cases of acromegaly in the US is projected to increase by 11.8% over the next decade

The diagnosed prevalent cases of acromegaly in the seven major markets (7MM*) combined is projected to increase from 43,220 cases in 2019 to 47,340 in 2029, at an annual growth rate (AGR) of 0.95%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Acromegaly and Gigantism – Epidemiology Forecast to 2029’, notes that […]

Pharma

Global IPF market set to reach $3.6bn by 2029

The idiopathic pulmonary fibrosis (IPF) market was valued at $2.5bn in 2019 across the seven major markets (7MM*), and is expected to grow to $3.6bn by 2029 with a compound annual growth rate (CAGR) of 3.8%, according to GlobalData, a leading data and analytics company. According to the company’s latest report: ‘Idiopathic Pulmonary Fibrosis: Opportunity Analysis […]

Automotive

Daimler eyes huge cost savings with Geely engine collaboration

Following the news that Daimler and Geely are to collaborate on developing and manufacturing next generation hybrid powertrains; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “Cost saving is clearly a major driver here. GlobalData estimates that Daimler could achieve cost savings of up to EUR1,800 per vehicle […]

Prev 1 2 3 4 5 6 … 15 Next

Following landmark approval, Pfizer and BioNTech can use UK as test bed for cold chain distribution

Lifetime diagnosed prevalent cases of asthma in 7MM set to surpass 89 million in 2029

ENT market set to fully recover from COVID-19 pandemic in 2021 and exceed market value of $10.6bn by 2025

China to see over 14,400 diagnosed incident cases of acute lymphocytic leukemia by 2029 – the highest in the 8MM

Influenza cases down from last year in the US but COVID-19 increases the risks

Bladder cancer therapeutics market projected to exceed $5.5bn by 2028

Acute lymphocytic leukemia market is forecast to reach $2.26bn by 2029

US cannot wait on vaccines to curb pandemic as COVID-19 cases trend towards 100 million by July 2021

European oil companies lead way in renewable strategy with top six having over 28GW capacity in pipeline

Phase III data for Omecamtiv Mecarbil and Finerenone demonstrates reduced risk of cardiovascular events at AHA conference

Pancreatic ductal adenocarcinoma diagnosed incident cases set to reach 225,000 in 2029

Half of top 20 global innovative pharma companies by MCap reported positive MCap growth in Q3 2020

Gmax BioPharm looking to enter competitive PAH market with early stage drug GMA301

Global oil and gas contract activity report marginal increase during Q3 2020

FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1 diabetes space

3D printing market set to surge to over $60bn by 2030, driven by medical 3D printing

North America dominated global VC funding landscape during Q3 2020, while APAC emerged as bright spot

Diagnosed prevalent cases of acromegaly in the US is projected to increase by 11.8% over the next decade

Global IPF market set to reach $3.6bn by 2029

Daimler eyes huge cost savings with Geely engine collaboration

Browse

Company information